Increased IL-21 levels, also produced by Th17 cells, can induce tumor regression through expansion of CD8+ tumor-infiltrating lymphocytes in NSCLC as well as ovarian cancer and melanoma [115, 116] (Fig. 4). This evidence concerns the gene CD8A and neoplasm.